does retatrutide cause cancer vs Tirzepatide (2026): Differences in Weight Loss, Metabol – Revolution Health & Wellness Incretin triple agonist retatrutide (LY3437943)

This activity is designated for 1.50 AAPA Category 1 CME credits

The glucagon receptor agonism, whilst counterintuitive given glucagon's role in raising blood glucose, is thought to increase energy expenditure and promote hepatic fat oxidation whilst reducing lipogenesis effects that may offer potential benefits in metabolic dysfunction-associated steatotic liver disease (MASLD)

Effect of exenatide after short-time intensive insulin therapy on glycaemic remission maintenance in type 2 diabetes patients: a randomized controlled trial

We are likely to continue to see clinical trials include treatment of adiposity-related diseases as a component of obesity medication investigations

Back House Resolution HR1147 Congratulations to Dr Graeme Bell

Some changes in the eyelids and brow are expected because of aging and gravitys effect on our faces, and its mainly a cosmetic issue